PMI Guide PS Setting in Pressure Support-ventilated Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
Pressure support ventilation (PSV) is an assistant mechanical ventilation mode, that is widely implemented in mechanical ventilation treatment but there are no exact guidelines to guide PS setting. Traditional PS setting strategy (VT/PBW 6-8ml/kg and RR 20-30 breaths/min)has risks of excessive or insufficient assistance. Inspiratory muscle pressure index (PMI) is a noninvasive respiratory mechanical indicator and is available at the bedside. PMI was correlated with inspiratory effort and has the potential ability to predict low inspiratory effort and high inspiratory effort. The primary objective of this study is to investigate the clinical validity of a PMI-guided PS setting strategy. Specifically, the investigators aim to evaluate its impact on inspiratory effort as well as its potential for lung and diaphragm protection. Additionally, the investigators seek to assess the effect of this ventilation strategy on mechanical ventilation outcomes while evaluating the feasibility of our trial protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 9, 2025
July 1, 2024
2.3 years
July 1, 2023
January 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The proportion of conditions in the range of normal inspiratory effort per patient
the time from the start of PSV mode to the successful weaning of the ventilated patients
up to 48 hours
Secondary Outcomes (9)
The duration of mechanical ventilation
up to 28 days
Tracheostomy rate
up to 28 days
Reintubation rate
up to 28 days
Diaphragm thickness (Tdi)
up to 28 days
Diaphragm thicken fraction (TFdi)
up to 28 days
- +4 more secondary outcomes
Study Arms (2)
Experimental arm
EXPERIMENTALThe initial PS level is set up based on VT/PBW (6-8ml/kg) and RR (20-30 breaths/min) when patients are enrolled in the experimental arm. The following steps need to be repeated every 2 hours for 48 hours. Step 1: 3 times short EIOs (2-3s) are performed. At least 1 minute between each occlusion. PMI is calculated as the mean value of 3 measured values. Step 2: Clarify whether PMI is in the target range (PMI 0-2cmH2O). If yes, keep this PS level. If not, implement step 3. Step 3: A downward or upward PS setting adjustment is performed at a 1cmH2O interval. Every PS level is maintained for 3-5 minutes. PMI is measured again and step 3 is repeated until the PMI target is reached. Step 4: supplemental adjustment: PS setting needs to be returned to the previous level if the patient presents the following signs: VT \< 4 ml/Kg, RR \> 35 breaths/min, respiratory acidosis, respiratory distress, VT \> 10ml/Kg, Pplat \> 30 cmH2O, respiratory alkalosis.
Control arm
NO INTERVENTIONPatients randomized to the control arm need to continue to accept the traditional ventilation strategy which is VT/PBW (6-8ml/kg) and RR (20-30breaths/min) guide PS setting.
Interventions
Use PMI guide PS setting in pressure-supported ventilated patients and keep PMI within the target range (0-2cmH2O).
Eligibility Criteria
You may qualify if:
- Patients under PSV
- Predicted ventilated time of more than 48 hours.
You may not qualify if:
- Age less than 18 years old;
- Known pregnancy;
- BMI\>35kg/m2;
- Brain-stem or cervical cord injury;
- Known or clinically suspected elevated intracranial pressure (ICP\>18 mmHg);
- Nervus phrenicus or diaphragm injury;
- Broncho-pleural fistula;
- Chronic obstructive pulmonary disease (COPD);
- Pressure support ventilated time more than 48 hours before randomization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100071, China
Related Publications (1)
Gao R, Yang YL, Zhang L, Miao MY, Zhou JX. Use of pressure muscle index to guide pressure support ventilation setting: a study protocol and statistical plan for a prospective randomised controlled proof-of-concept trial. BMJ Open. 2024 Aug 3;14(8):e082395. doi: 10.1136/bmjopen-2023-082395.
PMID: 39097307DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 1, 2023
First Posted
July 27, 2023
Study Start
August 1, 2023
Primary Completion
December 1, 2025
Study Completion
December 31, 2025
Last Updated
January 9, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share